Collaborative Targeted Case Management in Improving Functional Status in Patients With Stage III-IV Cancer

NCT01721343 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 516

Last updated 2026-03-16

No results posted yet for this study

Summary

This randomized clinical trial studies collaborative targeted case management in improving functional status in patients with stage III-IV cancer. Collaborative targeted case management may improve functional mobility, improve quality of life, and reduce pain and health care utilization in patients with advanced cancer

Conditions

  • Cognitive/Functional Effects
  • Malignant Neoplasm
  • Pain

Interventions

BEHAVIORAL

telephone-based intervention

Undergo telephonic monitoring

OTHER

case management

Participate in an individualized conditioning program with an RCM

PROCEDURE

management of therapy complications

Undergo enhanced usual care with an RCM and PCM

PROCEDURE

physical therapy

Participate in an individualized conditioning program with an RCM

OTHER

questionnaire administration

Ancillary studies

PROCEDURE

quality-of-life assessment

Ancillary studies

PROCEDURE

management of therapy complications

Undergo enhanced usual care

PROCEDURE

assessment of therapy complications

Undergo enhanced usual care

OTHER

educational intervention

Participate in an individualized conditioning program with an RCM

PROCEDURE

management of therapy complications

Undergo enhanced usual care with an RCM

PROCEDURE

assessment of therapy complications

Undergo enhanced usual care with an RCM

PROCEDURE

assessment of therapy complications

Undergo enhanced usual care with an RCM and PCM

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH
  • Mayo Clinic

    lead OTHER

Principal Investigators

  • Andrea Cheville, M.D. · Mayo Clinic

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-11-07
Primary Completion
2017-11-14
Completion
2019-08-03

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01721343 on ClinicalTrials.gov